New York Life Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

New York Life Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,800	Closed	-$9.47M	–	855
2025 Q1	$9.47M	Buy	+71,800	New	+$8.95M	0.1%	192
2024 Q4	–	Sell	-11,247	Closed	-$823K	–	881
2024 Q3	$823K	Buy	11,247 +375	+3%	+$28.2K	0.01%	733
2024 Q2	$745K	Buy	10,872 +988	+10%	+$68.5K	0.01%	747
2024 Q1	$684K	Sell	9,884 -772	-7%	-$53.1K	0.01%	755
2023 Q4	$763K	Buy	+10,656	New	+$613K	0.01%	724

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York Life Investment Management's ITCI Position: Q2 2025 in Review

New York Life Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 71,800 shares — an estimated $9.47M sold.

New York Life Investment Management first reported a position in ITCI in Q4 2023 and held it in 5 quarters. The position peaked at $9.47M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

New York Life Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
New York Life Investment Management sold 71,800 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $9.47M.
New York Life Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2023 and held it in 5 quarters.
New York Life Investment Management's Intra-Cellular Therapies Inc. position peaked at $9.47M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on New York Life Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.